Imspex Diagnostics is pleased to announce the appointment of David Wilson to our board of directors as a Non-Executive Director. David brings over 30 years of international experience in the in-vitro diagnostic medical devices industry, providing deep expertise in mergers and acquisitions, business development, and global sales.

His vast experience includes leadership roles at Genzyme Corporation, Molecular Detection, and most recently at Avacta Group Plc., where he shaped commercial strategies for immunodiagnostics and drove the operational development of their diagnostics division. David’s leadership and vision will play a pivotal role in helping Imspex continue to deliver innovative testing solutions and grow our global footprint.

With David’s appointment, we are reaffirming our commitment to expanding our portfolio and advancing point-of-need diagnostic technologies to better serve clinical and industry partners.

For further details, please read our official press release